{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:00:28Z","timestamp":1761102028392,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"the Association for Glycogen Storage Disease (UK)"},{"name":"the Muscular Dystrophy Association (USA)"},{"name":"the Oswestry Institute of Orthopaedics"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.nmd.2012.06.348","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T20:33:09Z","timestamp":1342816389000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon"],"prefix":"10.1016","volume":"23","author":[{"given":"Kathryn E.","family":"Birch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros M.","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2012.06.348_b0005","first-page":"13","article-title":"Myopathy due to a defect in muscle glycogen breakdown","volume":"10","author":"McArdle","year":"1951","journal-title":"Clin Sci"},{"key":"10.1016\/j.nmd.2012.06.348_b0010","first-page":"CD007931","article-title":"Physical training for McArdle disease","volume":"12","author":"Quinlivan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2012.06.348_b0015","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","article-title":"McArdle disease: a clinical review","volume":"81","author":"Quinlivan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2012.06.348_b0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.nmd.2011.07.002","article-title":"Molecular and clinical study of McArdle\u2019s disease in a cohort of 123 European patients. Identification of 20 novel mutations","volume":"21","author":"Vieitez","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.06.348_b0025","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/hmg\/2.8.1291","article-title":"McArdle\u2019s disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases","volume":"2","author":"Bartram","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2012.06.348_b0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.20649","article-title":"Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay","volume":"29","author":"Nogales-Gadea","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2012.06.348_b0035","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.nmd.2008.06.384","article-title":"A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay","volume":"18","author":"Sohn","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.06.348_b0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM199307223290404","article-title":"Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle\u2019s disease)","volume":"329","author":"Tsujino","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2012.06.348_b0045","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)65447-8","article-title":"McArdle\u2019s disease. The unsolved mystery of the reappearing enzyme","volume":"154","author":"Martinuzzi","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2012.06.348_b0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0960-8966(98)00127-8","article-title":"McArdle\u2019s disease associated with homozygosity for the missense mutation Gly204Ser of the myophosphorylase gene in a Spanish patient","volume":"9","author":"Rubio","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.06.348_b0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.57.2.217","article-title":"A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease","volume":"57","author":"Fernandez","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2012.06.348_b0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bcmd.2009.12.001","article-title":"Recommendations for treating patients with Gaucher disease with emerging enzyme products","volume":"44","author":"Cox","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.nmd.2012.06.348_b0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","article-title":"Therapeutic approaches in glycogen storage disease type II\/Pompe disease","volume":"5","author":"Schoser","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nmd.2012.06.348_b0070","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"Sermet-Gaudelus","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nmd.2012.06.348_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09031936.00120910","article-title":"Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis","volume":"38","author":"Wilschanski","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.nmd.2012.06.348_b0080","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced read-through of stop codons in Duchenne muscular dystrophy","volume":"67","author":"Malik","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2012.06.348_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ejhg.2009.122","article-title":"In vitro read-through of termination codons by gentamycin in the Stuve\u2013Wiedemann syndrome","volume":"18","author":"Bellais","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2012.06.348_b0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgm.1140","article-title":"Drug-induced read-through of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes","volume":"10","author":"Allamand","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.nmd.2012.06.348_b0095","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","article-title":"Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides","volume":"39","author":"Floquet","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2012.06.348_b0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0960-8966(97)00062-X","article-title":"A splice-site mutation causing ovine McArdle\u2019s disease","volume":"7","author":"Tan","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.06.348_b0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/mus.880180710","article-title":"Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle","volume":"18","author":"Angelos","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2012.06.348_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(95)00014-3","article-title":"Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle\u2019s disease","volume":"6","author":"Tsujino","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.06.348_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013164","article-title":"Expression of glycogen phosphorylase isoforms in cultured muscle from patients with McArdle\u2019s disease carrying the p.R771PfsX33 PYGM mutation","volume":"5","author":"Nogales-Gadea","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2012.06.348_b0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/geno.1996.0177","article-title":"The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression","volume":"33","author":"Lennon","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.nmd.2012.06.348_b0125","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1073\/pnas.242603899","article-title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences","volume":"99","author":"Strausberg","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2012.06.348_b0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1471-4159.2003.01644.x","article-title":"Immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies","volume":"85","author":"Pfeiffer-Guglielmi","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.nmd.2012.06.348_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.nmd.2012.06.348_b0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20050808","article-title":"Subcellular localization of rat Abca5, a rat ATP-binding-cassette transporter expressed in Leydig cells, and characterization of its splice variant apparently encoding a half-transporter","volume":"393","author":"Petry","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.nmd.2012.06.348_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.20111","article-title":"Splicing of scorpion toxin gene BmKK2 in HEK 293T cells","volume":"20","author":"Zhijian","year":"2006","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.nmd.2012.06.348_b0150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1083\/jcb.200611086","article-title":"Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies","volume":"178","author":"Durand","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2012.06.348_b0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature08999","article-title":"Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay","volume":"465","author":"Pastor","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2012.06.348_b0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm1310","article-title":"Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics","volume":"5","author":"Maquat","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nmd.2012.06.348_b0165","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/pro.5560010904","article-title":"Multiple phosphate positions in the catalytic site of glycogen phosphorylase: structure of the pyridoxal-5\u2032-pyrophosphate coenzyme\u2013substrate analog","volume":"1","author":"Sprang","year":"1992","journal-title":"Protein Sci"},{"key":"10.1016\/j.nmd.2012.06.348_b0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Read-through of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J Mol Med"},{"key":"10.1016\/j.nmd.2012.06.348_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2012.06.348_b0180","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1084\/jem.20081940","article-title":"Nonaminoglycoside compounds induce read-through of nonsense mutations","volume":"206","author":"Du","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.nmd.2012.06.348_b0185","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0091270006297140","article-title":"Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers","volume":"47","author":"Hirawat","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nmd.2012.06.348_b0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","article-title":"Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency","volume":"66","author":"Schroers","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2012.06.348_b0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon read-through: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2012.06.348_b0200","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","article-title":"Translational read-through by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo","volume":"18","author":"Heier","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2012.06.348_b0205","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","article-title":"Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease","volume":"132","author":"Vissing","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2012.06.348_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0925-4439(95)00060-H","article-title":"McArdle\u2019s disease-muscle glycogen phosphorylase deficiency","volume":"1272","author":"Bartram","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nmd.2012.06.348_b0215","article-title":"Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB1 alleles causing G(M1)-gangliosidosis and Morquio B disease","author":"Fantur","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2012.06.348_b0220","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cbic.200900442","article-title":"Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin","volume":"10","author":"Luan","year":"2009","journal-title":"Chembiochem"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896612005305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896612005305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:00:51Z","timestamp":1760774451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896612005305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0960896612005305"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2012.06.348","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2012.06.348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}